Back
Pliant Therapeutics Quote, Financials, Valuation and Earnings

Get Instant Access To Today's Top Options List!
View this list for FREE now!
Sell
28
PLRX
Pliant Therapeutics
Last Price:
26.02
Seasonality Move:
-19.58%
7 Day Trial
ALL ACCESS PASS
$
7

Ready For A Once In A Generation Opportunity In The Copper Space?
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!Pliant Therapeutics Price Quote
$26.02
-0.03 (-0.34%)
(Updated: March 24, 2023 at 5:24 AM ET)
Pliant Therapeutics Key Stats
Sell
28
Pliant Therapeutics (PLRX)
is a Sell
Day range:
$25.63 - $26.67
52-week range:
$3.97 - $36.64
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
112.93
P/B ratio:
4.9%
Volume:
455K
Avg. volume:
422.8K
1-year change:
237.87%
Market cap:
$1.5B
Revenue:
$9.7M
EPS:
$-2.97
How Much Does Pliant Therapeutics Make?
-
How Much Are Pliant Therapeutics's Sales Annually?
PLRX Revenues are $9.7M -
How Much Profit Does Pliant Therapeutics's Make A Year?
PLRX net income is -$123.3M
Is Pliant Therapeutics Growing As A Company?
-
What Is Pliant Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.02% -
What Is Pliant Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Pliant Therapeutics Stock Price Performance
-
Did Pliant Therapeutics Stock Go Up Last Month?
Pliant Therapeutics share price went down by -18.85% last month -
Did PLRX's Share Price Rise Over The Last Year?
PLRX share price rose by 237.87% over the past 1 year
What Is Pliant Therapeutics 52-Week High & Low?
-
What Is Pliant Therapeutics’s 52-Week High Share Price?
Pliant Therapeutics has traded as high as $36.64 over the past 52 weeks -
What Is Pliant Therapeutics’s 52-Week Low Share Price?
Pliant Therapeutics has traded as low as $3.97 over the past 52 weeks
Pliant Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Pliant Therapeutics?
-
How Much Debt Does Pliant Therapeutics Have?
Total long term debt quarterly is $9.9M -
How Much Cash Does Pliant Therapeutics Have?
Cash and short term investments quarterly total is $331.2M -
What Is Pliant Therapeutics’s Book Value Per Share?
Book value per share is 6.40
Is Pliant Therapeutics Cash Flow Positive?
-
What Is PLRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$94.6M -
What Is Pliant Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $226.9M -
What Is Pliant Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$150.2M
Pliant Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PLRX return on invested capital is -51.36% -
What Is Pliant Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -46.34% -
What Is PLRX Return On Equity?
ROE is a measure of profitability and is -52.66%
Pliant Therapeutics Earnings Date & Stock Price
-
What Is Pliant Therapeutics's Stock Price Today?
A single share of PLRX can be purchased today for 26.05 -
What Is Pliant Therapeutics’s Stock Symbol?
Pliant Therapeutics trades on the nasdaq under the ticker symbol: PLRX -
When Is Pliant Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Pliant Therapeutics is scheduled on May 9, 2023 -
When Is PLRX's next ex-dividend date?
Pliant Therapeutics's next ex-dividend date is March 24, 2023 -
How To Buy Pliant Therapeutics Stock?
You can buy Pliant Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Pliant Therapeutics Competitors
-
Who Are Pliant Therapeutics's Competitors?
Below is a list of companies who compete with Pliant Therapeutics or are related in some way:
Pliant Therapeutics Dividend Yield
Data Unavailable
Pliant Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -2.86% |
Revenue: | -1.7% | 62.25% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 48.27 |
Upside from Last Price: | 85.31% |